Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase Chronic neuroinflammation mediated by microglia, the resident immune cells of the brain, has been implicated as a key event driving the delayed and progressive loss of dopaminergic neurons in idiopathic Parkinsons disease (PD). Post-mortem analyses of PD patients have revealed the activation of microglia and an accumulation of proinflammatory factors in the substantia nigra (SN). Similarly, Gram-negative bacterial endotoxin lipopolysaccharide (LPS) induces microglia-mediated neuroinflammation in the brains of laboratory animals and recapitulates the delayed and progressive nature of nigral dopaminergic degeneration. Previous reports have shown that humans exposed to LPS also develop Parkinsonian syndromes. However, how acute microglial activation becomes chronic and toxic to dopaminergic neurons is poorly understood. Recent findings have indicated that neurogenic signals can modulate microglial activity and function. Substance P (SP), produced in striatonigral-projecting neurons, has been shown to amplify proinflammatory responses in the CNS. This proinflammatory peptide has been implicated in the pathogenesis of PD due to its ability to stimulate dopamine (DA) release and modulate motor behaviors. However, the functional role of SP in the regulation of neuroinflammation and dopaminergic neuron survival remains elusive. Dopaminergic neurons in the SN are more susceptible to oxidative and inflammatory insults than other types of neurons. We and others have previously reported that SP is capable of stimulating or augmenting microglial activation to produce superoxide and proinflammatory cytokines in vitro. Given that SP is most concentrated in the SN, which contains a disproportionately high density of microglia (approximately 4.5 times that of other regions, we hypothesized that SP may regulate microglial activity in vivo, thereby exacerbating dopaminergic neurodegeneration in neuroinflammatory conditions. To test our hypothesis, we treated mice or various primary cell cultures with two commonly used toxins, LPS- or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, in animal)/1-methyl-4-phenylpyridinium (MPP+, in cell culture), which cause dopaminergic neurodegeneration. Several strains of mice deficient in SP (TAC1-/-), the SP receptor (NK1R-/-) or NADPH oxidase (NOX2;gp91phox-/-, the functional catalytic subunit of NOX2) were used. We found that SP potentiated LPS and MPTP-induced toxic effects on nigrostriatal dopaminergic neurons by enhancing microglia-mediated neuroinflammation. Importantly, we discovered that the activation of microglial NOX2 by ultra-low concentrations of SP was a novel, NK1R-independent signaling pathway responsible for the synergistic neurotoxicity induced by SP with either LPS or MPTP. These findings strongly suggest that SP facilitates neuroinflammation induced by toxins and plays a key role in damaging dopaminergic neurons via a novel NK1R-independent mechanism.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
U.S. National Inst of Environ Hlth Scis
Zip Code
Dang, Duy-Khanh; Shin, Eun-Joo; Kim, Dae-Joong et al. (2018) Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated ?-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor. J Neuroinflammation 15:52
Zhang, Wei; Gao, Jun-Hua; Yan, Zhao-Fen et al. (2018) Minimally Toxic Dose of Lipopolysaccharide and ?-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation. Mol Neurobiol 55:619-632
Lee, Sheng-Yu; Wang, Tzu-Yun; Chen, Shiou-Lan et al. (2018) Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study. Alcohol Clin Exp Res 42:1044-1050
Hou, Liyan; Li, Qiujuan; Jiang, Liping et al. (2018) Hypertension and Diagnosis of Parkinson's Disease: A Meta-Analysis of Cohort Studies. Front Neurol 9:162
Dang, Duy-Khanh; Shin, Eun-Joo; Kim, Dae-Joong et al. (2018) PKC?-dependent p47phox activation mediates methamphetamine-induced dopaminergic neurotoxicity. Free Radic Biol Med 115:318-337
Lai, Ching-Long; Lu, Chun-Chung; Lin, Hui-Ching et al. (2018) Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: A potential role of BDNF up-regulation. J Formos Med Assoc :
Hashiguchi, Takuyu; Shindo, Sawako; Chen, Shih-Heng et al. (2018) Sulfotransferase 4A1 Increases Its Expression in Mouse Neurons as They Mature. Drug Metab Dispos 46:860-864
Wang, Tzu-Yun; Lee, Sheng-Yu; Hu, Ming-Chuan et al. (2017) More inflammation but less brain-derived neurotrophic factor in antisocial personality disorder. Psychoneuroendocrinology 85:42-48
Lu, Ru-Band; Lee, Sheng-Yu; Wang, Tzu-Yun et al. (2017) Long-term heroin use was associated with the downregulation of systemic platelets, BDNF, and TGF-?1, and it contributed to the disruption of executive function in Taiwanese Han Chinese. Drug Alcohol Depend 179:139-145
Tseng, Jui-Heng; Xie, Ling; Song, Sheng et al. (2017) The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology. Cell Rep 20:2169-2183

Showing the most recent 10 out of 86 publications